摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(1-pyrazolyl)-1,3-thiazine | 1330562-73-6

中文名称
——
中文别名
——
英文名称
2-(1-pyrazolyl)-1,3-thiazine
英文别名
2-pyrazol-1-yl-5,6-dihydro-4H-1,3-thiazine
2-(1-pyrazolyl)-1,3-thiazine化学式
CAS
1330562-73-6
化学式
C7H9N3S
mdl
——
分子量
167.235
InChiKey
ZRMACCVNOIFKCV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    55.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    copper(II) choride dihydrate 、 2-(1-pyrazolyl)-1,3-thiazine甲醇 为溶剂, 以53%的产率得到[{CuCl(PzTz)}2(μ-Cl)2]
    参考文献:
    名称:
    吡唑/噻嗪配体的取代基对氯桥联Cu(ii)配合物的磁性的影响†
    摘要:
    我们已经合成并表征了二聚体铜(II)配合物[{CuCl(PzTz)} 2(μ-Cl)2 ],[{CuCl(DMPzTz)} 2(μ-Cl)2 ]和[{CuCl(DPhPzTz) } 2(μ-Cl)2 ]和单体络合物[CuCl 2(DMPzTz)](PzTz = 2-(1-吡唑基)-1,3-噻嗪,DMPzTz = 2-(3,5-二甲基-1-吡唑基)-1,3-噻嗪和DPhPzTz = 2-(3,5-二苯基-1-吡唑基)-1,3-噻嗪)。单晶X射线衍射研究表明,铜周围的几何形状(II在二聚体单元中的中心是扭曲的平方金字塔,而单体化合物呈现出扭曲的平方平面配位。根据配合物的X射线结构和EPR光谱研究并结合DFT计算,讨论了配合物的电子和磁性。与结构相似的铜的磁结构比较(Ⅱ))也可以进行。DFT计算表明,双核物质比单核物质更稳定,尽管包含甲基或苯基取代基会引起单核形式的重要稳定。DFT计算无法预测复
    DOI:
    10.1039/c7nj01581j
  • 作为产物:
    描述:
    吡唑3-氯苯基 异硫氰酸盐 在 sodium hydride 作用下, 以 甲苯 为溶剂, 反应 7.0h, 以55.6%的产率得到2-(1-pyrazolyl)-1,3-thiazine
    参考文献:
    名称:
    Zinc(II) complexes with novel 1,3-thiazine/pyrazole derivative ligands: Synthesis, structural characterization and effect of coordination on the phagocytic activity of human neutrophils
    摘要:
    The new ligands 2-(1-pyrazolil)-1,3-thiazine (PzTz), 2-(3,5-dimethyl-1-pyrazolil)-1,3-thiazine (DMPzTz) and 2-(3,5-diphenyl-1-pyrazolil)-1,3-thiazine (DPhPzTz) and the complexes [ZnCl2(H2O)(PzTz)] (1), [ZnCl2(DMPzTz)] (2) and [ZnCl2(DPhPzTz)] (3) have been isolated and then characterized by elemental analysis, IR spectra and UV-Vis spectroscopy. Besides, the crystal structure of ligands PzTz and DPhPzTz and complexes 1-3 have been determined by single-crystal X-ray diffraction. In 1, the geometry around the Zn(II) atom can be considered a highly distorted trigonal bipyramid, with the metallic atom bonded to two chlorine atoms, one water molecule and one bidentate PzTz ligand. In 2 and 3, the environment around the metal ion can be described as a distorted tetrahedron with the zinc atom coordinated to one bidentate organic ligand molecule and two chloro ligands. In addition, the phagocytic function of human neutrophils treated with complexes 1-3, their organic ligands and ZnCl2 has been evaluated. The activity of cells enhanced in samples treated with 1, 2 and 3 with respect to the ones to which the inorganic salt, PzTz. DMPzTz or DPhPzTz were added. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.poly.2011.07.014
点击查看最新优质反应信息

文献信息

  • Effects of the substituents of pyrazole/thiazine ligands on nuclearity of Cu(II) nitrate complexes
    作者:P. Torres-García、E. VIÑUelas-Zahínos、F. Luna-Giles、A. Bernalte-García
    DOI:10.1080/00958972.2012.718764
    日期:2012.10.20
    [Cu(H2O)(PzTz)2](NO3)2 (1), [Cu(μ-NO3)(NO3)(DMPzTz)] n (2), and [Cu(NO3)(DPhPzTz)}2(μ-NO3)2] (3) [PzTz = 2-(1-pyrazolyl)-1,3-thiazine, DMPzTz = 2-(3,5-dimethyl-1-pyrazolyl)-1,3-thiazine, DPhPzTz = 2-(3,5-diphenyl-1-pyrazolyl)-1,3-thiazine] have been prepared and characterized by elemental analysis, electronic spectroscopy, IR spectroscopy, electron paramagnetic resonance spectroscopy, magnetic susceptibility
    [Cu(H2O)(PzTz)2](NO3)2 (1)、[Cu(μ- )( )(DMPzTz)] n (2) 和 [Cu( )(DPhPzTz)}2( μ- )2] (3) [PzTz = 2-(1-吡唑基)-1,3-噻嗪DMPzTz = 2-(3,5-二甲基-1-吡唑基)-1,3-噻嗪,DPhPzTz = 2-(3,5-二苯基-1-吡唑基)-1,3-噻嗪]已制备并通过元素分析、电子光谱、红外光谱、电子顺磁共振光谱、磁化率测量和单晶 X-射线衍射。已分析配体大小对与 Cu(II) 配位的影响。这三个配合物是五坐标,配位几何可以描述为 1 的扭曲三角双锥或 2 和 3 的扭曲四角锥。 由于配体引起的应变,1 是单体复合阳离子,而 2是聚合物,3是二聚体。
  • Influence of ligand lipophilicity in Pt(II) complexes on their antiproliferative and apoptotic activities in tumour cell lines
    作者:Elena Fernández-Delgado、Samuel Estirado、Javier Espino、Emilio Viñuelas-Zahínos、Francisco Luna-Giles、Ana B. Rodríguez Moratinos、José A. Pariente
    DOI:10.1016/j.jinorgbio.2021.111688
    日期:2022.2
    coordination of bioactive ligands to transition metals, which could improve biological activity. Moreover, the incorporation of aromatic groups to ligands may allow an enhanced lipophilicity that can influence the cellular uptake and accumulation of the metallodrugs, thus increasing their activity. Herein, we have reported the synthesis and characterization of four Pt(II) complexes [PtCl2(L)], where
    药物开发最广泛使用的策略之一是将生物活性配体与过渡属配位,这可以提高生物活性。此外,芳香基团与配体的结合可以提高亲脂性,从而影响属药物的细胞摄取和积累,从而提高它们的活性。在此,我们报道了四种 Pt(II) 配合物 [PtCl 2(L)],其中 L = 2-(1-吡唑基)-2-噻唑啉 (PzTn)、2-(1-吡唑基)-1,3-噻嗪 (PzTz)、2-(3,5-diphenyl-1 -吡唑基)-2-噻唑啉 (DPhPzTn) 或 2-(3,5-二苯基-1-吡唑基)-1,3-噻嗪 (DPhPzTz)。该研究旨在分析它们在上皮性宫颈癌HeLa、人早幼粒细胞白血病HL-60和人组织细胞淋巴瘤U-937肿瘤细胞系中的潜在抗癌能力,并检查有机配体的结构因素是否可能影响其生物活性。我们的研究结果表明,就细胞毒性而言,PtDPhPzTn 和 PtDPhPzTz 比它们的亲脂性较低的对应物(PtPzTn
  • Influence of steric strain of S,N-heterocycles derivative ligands on the coordination geometry in cadmium(II) nitrato complexes
    作者:P. Torres-García、R. Pedrero-Marín、F. Luna-Giles、A.V. Huertas-Sánchez、E. Viñuelas-Zahínos
    DOI:10.1016/j.poly.2011.09.033
    日期:2012.1
    The new ligands 2-(3,5-dimethyl-1-pyrazolyl)-2-thiazoline (DMPyTn) and 2-(3,5-diphenyl-1-pyrazolyl)-2-thiazoline (DPhPyTn) have been synthesized and characterized, and six cadmium(II) nitrato complexes with these two ligands and four other pyrazole/S,N-heterocyclic derivative ligands with different steric features, previously reported, have been prepared and structurally characterized by means of elemental analysis, single crystal X-ray diffraction and IR spectra, with the objective of determining the role played by the steric strains of the ligands on the metal ion coordination index and geometry. The effect of two factors has been analyzed: the bulk of the pyrazole ring substituents and the size of the S,N-heterocycle. The data indicate that there is a clear influence of the size of the organic ligands on the coordination environment of the Cd(II) ion. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)